Heartburn and other related symptoms are independent of body mass index in irritable bowel syndrome

Revista Espanola de Enfermedades Digestivas

Volumn 102, Issue 4, 2010, Pages 229-233

  Schmulson, Max ^a   Pulido, D ^a   Escobar, C ^a   Farfan Labone B ^a   Gutierrez Reyes G ^a   Lopez Alvarenga J C ^b  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Body mass index; Dyspepsia; Heartburn; Irritable bowel syndrome (IBS) epidemiology diagnosis; Mexico; Nausea; Rome II criteria

Indexed keywords

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; EPIGASTRIC PAIN; FEMALE; HEARTBURN; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NAUSEA; OBESITY; QUESTIONNAIRE; SYMPTOMATOLOGY; THORAX PAIN; VOMITING;

EID: 77954975729     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: 10.4321/S1130-01082010000400002     Document Type: Article

References (25)

1. Zimmerman J, Hershcovici T. Bowel symptoms in non-erosive gastroesophageal reflux disease: nature, prevalence, and relation to Acid reflux. J Clin Gastroenterol. 2008; 42: 261-5.
2. Nastaskin I, Mehdikhani E, Conklin J, Park S, Pimentel M. Studying the overlap between IBS and GERD: a systematic review of the literature. Dig Dis Sci 2006; 51: 2113-20.
3. Raftopoulos Y, Papasavas P, Landreneau R, Young JC, Fowler D, Bergamaschi R. Clinical outcome of laparoscopic antireflux surgery for patients with irritable bowel syndrome. Surg Endosc 2004; 18: 655-9.
4. Fass R, Tougas G. Functional heartburn: the stimulus, the pain, and the brain. Gut 2002; 51: 885-92.
5. Clouse RE, Richter JE, Heading RC, Janssens J, Wilson JA. Functional esophageal disorders. Gut 1999; 45(Supl. II): II31-II6.
6. Choi CW, Kim GH, Song CS, Wang SG, Lee BJ, I H, et al. Is obesity associated with gastro pharyngeal reflux disease? World J Gastroenterol 2008; 14: 265-71.
7. Dore MP, Maragkoudakis E, Fraley K, Pedroni A, Tadeu V, Realdi G, et al. Diet, lifestyle and Gender in gastro-esophageal reflux disease. Dig Dis Sci 2008; 53: 2027-32.
8. Dickman R, Feroze H, Fass R. Gastroesophageal reflux disease and irritable bowel syndrome: a common overlap syndrome. Curr Gastroenterol Rep 2006; 8: 261-5.
9. Nocon M, Labenz J, Jaspersen D, Meyer-Sabellek W, Stolte M, Lind T, et al. Association of body mass index with heartburn, regurgitation and esophagitis: results of the progression of gastroesophageal reflux disease study. J Gastroenterol Hepatol 2007; 22: 1728-31.
10. Riedl A, Schmidtmann M, Stengel A, Goebel M, Wisser AS, Klapp BF, et al. Somatic comorbidities of irritable bowel syndrome: a systematic analysis. J Psychosom Res 2008; 64: 573-82.
11. Thompson WG. Research diagnostic questions for functional gastrointestinal disorders Rome II modular questionnaire. In: Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE, editors. Rome II: The Functional Gastrointestinal Disorders. Lawrence: Allen Press Inc; 2000. p. 670-88.
12. Schmulson M, Ortíz O, Santiago-Lomeli M, Gutiérrez-Reyes G, Gutiérrez-Ruiz MC, Robles-Díaz G, et al. Frequency of functional bowel disorders among healthy volunteers in Mexico City. Dig Dis 2006; 24: 342-7.
13. James PT, Leach R, Kalamara E, Shayeghi M. The worldwide obesity epidemic. Obes Res 2001; 9 (Supl. 4): 228S-33S.
14. Schmulson M. Heartburn according to Rome II in Spanish-Mexico: gastroesophageal reflux must be ruled out. Rev Gastroenterol Mex 2009; 74: 74-6.
15. Martín-Echevarría E, Pereira Juliá A, Torralba M, Arriola Pereda G, Martín Dávila P, Mateos J, et al. Evaluación del uso de los inhibidores de la bomba de protones en un ser vicio de medicina interna. Rev Esp Enferm Dig 2008; 100: 76-81.
16. Tack J, Caenepeel P, Arts J, Lee KJ, Sifrim D, Janssens J. Prevalence of acid reflux in functional dyspepsia and its association with symptom profile. Gut 2005; 54: 1370-6.
17. Westbrook JI, Talley NJ. Empiric clustering of dyspepsia into symptom subgroups: a population-based study. Scand J Gastroenterol 2002; 37: 917-23.
18. Fischler B, Tack J, De Gucht V, Shkedy ZI, Persoons P, Broekaert D, et al. Heterogeneity of symptom pattern, psychosocial factors, and pathophysiological mechanisms in severe functional dyspepsia. Gastroenterology 2003; 124: 903-10.
19. Kwan AC, Bao TN, Chakkaphak S, Chang FY, Ke MY, Law NM, et al. Validation of Rome II criteria for functional gastrointestinal disorders by factor analysis of symptoms in Asian patient sample. J Gastroenterol Hepatol 2003; 18: 796-802.
20. Whitehead WE, Bassotti G, Palsson O, Taub E, Cook EC 3rd, Drossman DA. Factor analysis of bowel symptoms in US and Italian populations. Dig Liver Dis 2003; 35: 774-83.
21. Alpers D. Multidimensionality of symptom complexes in irritable bowel syndrome and other functional gastrointestinal disorders. J Psychosom Res 2008; 64: 567-72.
22. Nimnuan C, Rabe-Hesketh S, Wessely S, Hotopf M. How many functional somatic syndromes? J Psychosom Res 2001; 51(4): 549- 57.
23. Talley NJ, Holtmann G, Agréus L, Jones M. Gastrointestinal symptoms and subjects cluster into distinct upper and lower groupings in the community: a four nations study. Am J Gastroenterol 2000; 95: 1439-47.
24. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2002; 122: 1140-56.
25. Morgan D, Schmulson M, Cortes L, Squella F, Domínguez R, Rey E, et alF. The multinational translation and validation of the Spanish Rome III adult diagnostic questionnaire. Am J Gastroenterol 2008; 103(S1): S477-8.